Category Archives: Testosterone Replacement Therapy

New York Long-term testosterone replacement therapy improves both sexual and urinary functions as well as quality of life for men suffering from a condition due to deficiency of the hormone, according to a study.

Testosterone is a steroid hormone involved in the regulation of sexual function, urinary health and metabolism as well as a number of other critical functions.

For most men, testosterone concentration declines slowly with age and may not cause immediate major symptoms.

However, some men may experience a host of signs and symptoms constituting a clinical condition called Testosterone Deficiency (TD), or male hypogonadism, which is attributed to insufficient levels of testosterone.

Office Portrait of MED Prof. Dr. Abdulmaged TraishPhoto by Vernon Doucette for Boston University Photography

As a result, they experience symptoms as varied as erectile dysfunction, low energy, fatigue, depressed mood and an increased risk of diabetes.

The study, published in the Journal of Urology, investigated the effects of long-term testosterone replacement therapy on urinary health and sexual function as well as quality of life in men with diagnosed, symptomatic testosterone deficiency.

More than 650 men in their 50s and 60s enrolled in the study, some with unexplained testosterone deficiency and others with known genetic and auto-immune causes for their hypogonadism.

It is thought that testosterone treatment in men may increase prostate size and worsen lower urinary tract symptoms, said Abdulmaged Traish, Professor of Urology at Boston University School of Medicine in the US.

However, the researchers discovered that despite increased prostate size in the group that received testosterone therapy, there were fewer urinary symptoms such as frequent urination, incomplete bladder emptying, weak urinary stream and waking up at night to urinate.

In addition to these subjective improvements, the researchers conducted objective testing that showed that those men treated with testosterone emptied their bladders more fully.

Finally, testosterone treatment also increased the scores patients received on assessments of their erectile/sexual health and general quality of life, the study said.

Related

Read the original post:
Testosterone therapy improves sexual functions - India New England

Report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products.

This press release was orginally distributed by SBWire

Albany, NY -- (SBWIRE) -- 08/16/2017 -- The topic of Hypogonadism can be an embarrassing subject for an affected male. Nevertheless, it's important that any man battling the symptoms of Hypogonadism to get over his embarrassment and be taken care of by a medical professional. A new pipeline study, related to the therapeutics activities for male hypogonadism has been recently broadcasted to the wide repository of Market Research Hub (MRH), with the title of "Male Hypogonadism-Pipeline Insight, 2017". The study highlights the pharmacological action of various therapeutics and their history of research and development activities.

Request Free Sample Report : http://www.marketresearchhub.com/enquiry.php?type=S&repid=1265411

Male hypogonadism is defined as the failure of the testes to produce androgen, sperm or both. Although the disorder is extremely common, its exact prevalence is uncertain. It is a condition in which the body doesn't produce enough testosterone, the hormone that plays a key role in masculine growth and development during puberty. It may adversely affect multiple organ functions and quality of life. Signs and symptoms depend on when the condition develops. The research analyses its symptoms, which include fatigue, hot flashes, infertility, decrease in muscle mass and loss of bone mass (osteoporosis). When hormone levels decline, men can easily experience significant psychological and physical changes.

Moreover, this study provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The coverage of pipeline products based on the numerous stages of development ranging from early development to approved or issued stage. In this subsequent section, details of foremost pipeline products which includes, product description, licensing and collaboration details and other developmental activities are also mentioned. This study has been built using proprietary databases along with latest updates and featured news & press releases from various university sites and industry-specific third party sources.

Looking to the therapeutics overview, the research studies that the levels of testosterone in men start to fall after the age of 40. It has been estimated that 8.4% of men aged 5079 years have testosterone deficiency. Some types of male hypogonadism can be treated with testosterone replacement therapy. There is a lot of research in progress to find out more about the effects of testosterone in older men and also whether the use of testosterone replacement therapy would have any benefits.

Browse Full Report with TOC - http://www.marketresearchhub.com/report/male-hypogonadism-pipeline-insight-2017-report.html

For a competitive analysis, the research has listed key companies operating in the market, focusing on their research and development efforts, adoption to changing trends and their efforts to discover new therapeutics for male hypogonadism. Also, the report covers dormant and discontinued pipeline projects related to the Male Hypogonadism. With this information, the new entrants in the market can modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress.

Enquire about this Report - http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1265411

About Market Research HubMarket Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH's expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us90 State Street,Albany, NY 12207,United StatesToll Free : 866-997-4948 (US-Canada)Tel : +1-518-621-2074Email : press@marketresearchhub.comWebsite : http://www.marketresearchhub.com/Read Industry News at - https://www.industrynewsanalysis.com/

For more information on this press release visit: http://www.sbwire.com/press-releases/pipeline-landscape-of-male-hypogonadism-covering-therapeutic-assessment-and-drug-portfolio-in-2017-848559.htm

Here is the original post:
Pipeline Landscape of Male Hypogonadism Covering Therapeutic Assessment and Drug Portfolio in 2017 - Digital Journal

Testosterone is a major sex hormone produced in the testes of men. The pituitary gland is responsible for controlling the production of testosterone hormone. In the testes, luteinizing hormone binds to receptors on Leydig cells; this stimulates production and secretion of testosterone. Testosterone helps to develop the primary and secondary sexual characteristics in males. Development of sex organs, deeper voice, muscle mass, and facial hair all result from the sufficient production of this hormone. Testosterone deficiency as happens with age needs effective testosterone treatment.

Along with the development of sexual features, testosterone hormone also controls the following actions in a body:

With age, testosterone production declines, thus disturbing overall body functioning. Low levels of testosterone hormone lead to a condition termed as hypogonadism that can be treated with testosterone replacement therapy. Hypogonadism can be divided into two categories depending on the occurrence of pathology.

Primary Hypogonadism: It occurs at testicular level with high release of follicle stimulating hormone (FSH), luteinizing hormone (LH), and low release of testosterone.

Secondary Hypogonadism: It occurs at pituitary hypothalamic level with low or in some cases normal release of luteinizing hormone and follicle stimulating hormone along with low levels of testosterone hormone.

Testosterone replacement therapy effectively works to improve upon the conditions of primary and secondary hypogonadism.

Along with aging, there are some other factors that contribute toward low testosterone production and make a man go for testosterone treatment.

Deficient testosterone hormone levels can lead to many undesirable symptoms, like poor libido, lack of vitality, erectile dysfunction, declining muscle mass, osteoporosis, loss of body hair, depression, lower blood hemoglobin, memory loss, poor concentration, mood swings, mild anemia, disturbed cholesterol profile and a decrease in cognitive function that effects all of your activities. Testosterone therapy is the only possible way to cope with testosterone deficiency.

Before start of the testosterone treatment, there should be the right detection of the hormone deficiency. If you consult an expert doctor for testosterone therapy, he may prescribe you the blood test in the morning because testosterone levels are at peak during that time.

We, at Nationwide Synergy Inc, provide patients with best available options to treat their hormone deficiency.

Choosing one best option for testosterone therapy requires consultation with your physician. We have qualified physicians and doctors at our panel who provide expert guidance to the patients.

Stay Young and Healthy with Balanced Hormones Testosterone Replacement Therapy Is Your best Choice!

Follow this link:
Testosterone Replacement Therapy - Testosterone Treatment

Weve had a seemingly endless series of discussions about the various aspects of the transgender debate here, many of which focus on the continued and worrisome spread of normalization gender dysphoria in society, the military and beyond. But one of the side-bar aspects of this discussion has had to do with the world of sports. Whether youre talking about a girl wrestling against boys or comparing the Bobby Riggs vs Billy Jean King tennis match to Renee Richards, questions of gender bending in the competitive arena come with all sorts of complications.

Now another sport is being featured in this ongoing debate and its the world of competitive cycling. For the first time a man identifying as a woman will be racing in a USA Cycling sanctioned event in the womens category and competing against some of the top female cyclists. Jillian Bearden (formerly Jonathan) is going to be competing in the Colorado Classic and is able to do so because both the International Olympic Committee and Cycling USA have removed the requirement for transgender athletes to have their transition surgery prior to being able to compete. What theyve done instead is require that men transitioning to be women spend at least one year on medication to suppress their testosterone production, increase estrogen and keep their T levels below a certain, unspecified level. (It will come as no surprise that there are no parallel testing requirements for women identifying as men.) From theDenver Post:

The new rules simply require transwomen to keep testosterone below a certain level for a year before competing and must present a doctors note showing their testosterone levels are below the IOC threshold. The IOC recommendations include no restrictions for athletes transitioning to male.

USA Cycling was one of the first national governing bodies to embrace the new policy, thanks in part to Beardens help. She had the science to support the new rules.

As an elite male racer, she had regular benchmarks measuring her power and lactate threshold. After more than two years of blocking testosterone and boosting estrogen, her wattage output has dropped by 11.4 percent. That mirrors the performance gap between top-tier male and female athletes.

Bearden has done precisely that and claims that his performance has decreased substantially from his days cycling as a man. Because of that, the argument goes, theres no problem with him having any sort of unfair advantage.

Bearden has watched her performance ebb since beginning hormone-replacement therapy in 2015. As testosterone fades and estrogen grows, her fastest times on favorite climbs have slipped into what she calls the gutter.

It was tough realizing her hard-earned power, developed over more than a decade of elite-level bike racing, was waning.

I went from 16 minutes to 26, 27, 28 minutes, she said of her times on her those climbs. I was like holy Testosterone gives you this drive, this oomph, and I didnt have that push.

Ill confess I hadnt given much thought to this aspect of it. The difference in performance levels between men and woman in all of these sports is well known, and letting a guy compete with the women would be grossly unfair. But if you suppress his testosterone levels enough, will his performance really degrade far enough to keep things competitive?

Hed better have suppressed it a lot. I was looking over some of the current records for cycling in the 24 hour competitions on both road and track. (Thats the distance you can ride in 24 hours.) The womens road record currently stands at just under 470 miles. The mens record? 557 miles. The indoor and outdoor track records similarly have a disparity of one hundred miles or more in the mens favor. Is a vastly decreased T level enough to make that much of a difference? While its not being applied to gender dysphoria situations, several medical resources indicate that markedly lower levels have an impact, but precisely how much is unknown and can vary from individual to individual.

Because testosterone plays a role in building muscle, men with low T might notice a decrease in muscle mass. Studies have shown testosterone affects muscle mass, but not necessarily strength or function.

The major problem here is that we dont have a baseline to study. Because of a lack of professional or Olympic records (at least as far as I can find and they arent mentioned in the Denver Post article) we have no idea how great of a cyclist Jonathan Bearden was before he started riding as Jillian Bearden. If he winds up coming in at the back or in the middle of the pack Im sure everyone will be all smiles and say it was great having him in the race. But what has that really proved? The best woman cyclist in the world will no doubt be able to smoke a mediocre male rider while the top flight men would leave her in the dust based on current Olympic records. Were looking at a situation similar in some ways to the aforementioned tennis scenario with Renee Richards. Keep in mind that he was in his mid to late 30s already by the time he was entering tennis full time and was certainly competent, but was only ranked in the top 20 in the over 35 category. Yet when playing as a woman Richards reached a ranking of 20th overall (against the best female players of any age) in 1979 and reached the womens doubles finals at the US Open that year.

That leaves us with an open question as to how well hell do in this race and, perhaps more importantly, how well hell be received. Its been a rousing and supportive welcome thus far, but if Bearden waltzes in there and wins (or comes fairly close) having no real racing bona fides beforehand, do you suppose all of the female competitors are still going to be quite so supportive and welcoming?

Stay tuned. Well have some of those answers later this month.

Read the original post:
Yes, let's chat about that first female transgender pro cyclist shall we? - Hot Air

SALIDA Less than three years into her transition from Jonathan to Jillian, pro cyclist Jillian Bearden has once again found serenity on her bike. Now, using studies and stats collected during her long career, she's helping prove that transgender athletes change more than their names; they change their biology.

Bearden has watched her performance ebb since beginning hormone-replacement therapy in 2015. As testosterone fades and estrogen grows, her fastest times on favorite climbs have slipped into what she calls "the gutter."

It was tough realizing her hard-earned power, developed over more than a decade of elite-level bike racing, was waning.

Jillian Bearden will race in the Colorado Classic, her highest-level event ever after winning the Tour of Tuscon in her big-race debut as a female racer last fall. (Hyoung Chang / The Denver Post)

"I went from 16 minutes to 26, 27, 28 minutes," she said of her times on her those climbs. "I was like holy ... Testosterone gives you this drive, this oomph, and I didn't have that push. My muscles looked fairly big, but I did not have that push to drive that extra energy. I had good days and really, really bad days. But at the end of it all, I always know that I won the biggest race of all. I am here on planet Earth with my family, and it doesn't really matter how slow I am. I've already won."

On Thursday, when Bearden saddles up with the world's best female cyclists for the Colorado Classic in her hometown of Colorado Springs, she will be the first transwoman to race with a pro peloton in the United States. Thanks to recently relaxed International Olympic Committee rules governing transgender athletes, and USA Cycling's embrace of those new rules, Bearden has become a beacon for transathletes across the globe.

Bearden is basking in a light that saved her life. In late 2014, she was driving in the dark and pushed her car to 90 mph. She turned up her favorite tune and prepared to whip the steering wheel and end it all. The darkness was all-consuming, eclipsing all the outward trimmings of success: a family, a home, a job and elite-level talent on a bike.

But just before that fateful yank, Bearden said she felt "an angelic light" penetrate her overwhelming misery. Maybe it was from her mom. Or her brother, who had taken his life almost a decade earlier.

"Whatever it was, that presence brought me out, and the message to me was, 'Tell your mom. Just tell your mom,'" Jillian said.

Jillian told her mom. Then she told her spouse. And her kids. And now she's telling the world that, since her birth, despite the misplaced hardware and the name Jonathan, she is a woman. It's not just that she always wanted to be a woman. She is a woman.

"I would have killed myself that night, and no one would have ever known why. I always knew who I was, but I was in such turmoil," the 36-year-old said, sipping coffee before a high-speed criterium race on rain-soaked streets in Salida.

While she was ready to sacrifice her competitive life in the saddle to claim her gender, she wasn't going to let go of bike racing without a fight. Cycling is her therapy, she said.

"Riding my bike has saved my life many times over," said Bearden, who works as an electrical engineer.

After her brother killed himself in 2005, she pedaled. As she grappled with her gender dysphoria, she pedaled. When suicidal thoughts consumed her, she pedaled. After several thousand hours of training and racing, she was really good. By the time she came so close to ending her life, she had reached the highest levels of amateur cycling on both her mountain and road bikes. Racing was part of her identity. Staying competitive on the bike was vital as she transitioned.

Her growth to Jillian has included more than counseling: hormone therapy to block testosterone and add estrogen, laser hair removal and a public pivot to female. She's also worked with the IOC and USA Cycling to implement new rules for transgender athletes.

The IOC's 2003 rules governing transgender athletes required them to have gender-reassignment surgery to compete in Olympic sports.

"To require surgical anatomical changes as a precondition to participation is not necessary to preserve fair competition and may be inconsistent with developing legislation and notions of human rights," reads the IOC's November 2015 draft guidelines for transgender policies.

The new rules simply require transwomen to keep testosterone below a certain level for a year before competing and must present a doctor's note showing their testosterone levels are below the IOC threshold. The IOC recommendations include no restrictions for athletes transitioning to male.

USA Cycling was one of the first national governing bodies to embrace the new policy, thanks in part to Bearden's help. She had the science to support the new rules.

As an elite male racer, she had regular benchmarks measuring her power and lactate threshold. After more than two years of blocking testosterone and boosting estrogen, her wattage output has dropped by 11.4 percent. That mirrors the performance gap between top-tier male and female athletes.

Bearden says those results have fostered a welcoming environment among her fellow racers. And with her decrease in power documented, she's able to dismiss the argument that she's carrying her years of training and racing as a man into women's racing.

"I'm shocked and I'm blessed and so happy they have embraced me and bought me in and treated me like who I am: a woman," she said. "I think a lot of people have read about my work with the IOC and USAC, and they see my test results from before and after and they see me as legit. I mean, I'm here. I'm a woman. Let's race."

Michelle Henry, a Palmares Racing teammate, has been training with Bearden for several weeks to prepare for the Colorado Classic.

"There are a lot of us who really support her," she said. "As much as her mission is to help others who might be struggling through that really low spot she was in, for many of us, we want to help those people understand there is a lot of acceptance out there and we support them."

Bearden credits the support of her team and family with her mental fight to regain her competitive edge. As her power waned, her push became much more internal.

"The testosterone is gone, so you have to find a new way to get to the new you, and the new me was working on my mental game," she said. "Now it's all mental."

Bearden's steep decline in performance aligns with the first study of transgender athletes, published in 2015 in the Journal of Sporting Cultures and Identities by medical physicist Joanna Harper, who is advising the IOC on its transgender policies. Harper's study showed transwomen runners slowed and lost strength as they blocked testosterone and added estrogen.

Chuck Hodge, the technical director for USA Cycling, consulted with Bearden as American cycling's governing body crafted a policy that welcomed all athletes. With the IOC revising its recommendations for transwomen athletes, USA Cycling didn't need to go through a philosophical or political review, he said, so much as embrace "an update that really modernized our view.

"We basically said this is our policy and this is what's fair and this is what we are doing," he said.

Hodge worked with Bearden through tweaks, like making sure her former name didn't pop up with her times on a race's online results page. "That sounds small, but I can't imagine going through all these changes and then our automated system throws up their old name. Jillian has been very helpful and understanding through the process."

Hodge said he's been "somewhat shocked at the number of calls and emails" from athletes who are following Bearden's lead.

"This wasn't a hard decision," he said. "It's really just treating people fairly and equitably and with respect."

USA Cycling is at the forefront of Olympic-sport governing bodies that are crafting policies for transgender athletes. Athletes like Bearden, with her before-and-after power data, support more science-based decisions, said Ashland Johnson, the director of education and research at the Human Rights Campaign who recently conducted a training for U.S. Olympic Committee coaches and administrators to help embrace athletes of every stripe.

"We are seeing more of a move among governing bodies, where instead of making policies that are dependent on old stereotypes based on gender, decisions are based in science, inclusion and fairness," she said.

Things are moving in the right direction at the international and national level, but more needs to be done at the state level to make sure the Olympic pipeline of younger athletes can include transgender competitors, Johnson said.

"That K-12 arena is where everyone should be able to participate," Johnson said. "We want to increase inclusion at every level of sport, but especially K through 12."

Even with the welcome from her fellow competitors and her rising profile as a transathlete role model, Bearden is quick to admit that not one step of her journey has been easy. But it's better than it ever was.

Last fall, with her wife, Sarah, and their almost 3-year-old daughter cheering her on, she won Arizona's El Tour de Tucson, one of the largest road bike races in the country. The Trans National Women's Cycling Team she co-founded last year has 22 members from 15 states and Mexico. So far this season, she's competed in almost 20 races in Colorado and the West. In late July, she placed fifth in the Salida Classic criterium. The next day, she took third in the event's road race.

The Colorado Classic will be her highest-profile competition.

She's a podium contender, and she's ready for the hate that might bring. She got it aplenty after she won the Tucson race. Her Facebook and Strava pages were quickly stained with anonymous commenters seemingly irked by her talent. Recently, she's had to report online death threats to the police. Transwomen are disproportionately targeted for violence, and transgender people have a high suicide rate, with an estimated 41 percent of transgender adults saying they have attempted to kill themselves.

But for every bucketload of hostility, Bearden says she connects with one person who is inspired by her story. That makes it all worth it, she said. Since she began racing last year, she's developed friendships with more than 50 transgender cyclists across the world eager to follow her lead.

As more step forward to claim their gender, she said, momentum is building.

"I want to use the strength I was given through my transition and send ripples to people everywhere. At the end of the day, it could help save a life for someone in a dark place," she said. "I'm hoping that me being out in the public eye can give people the courage and safety to come out and do what they love and be who they are."

Read the original here:
Trans athlete proves transition is more than a name change - Colorado Daily

The medical community agrees that testosterone begins to decline gradually in most men by the time they reach the age of 30. If left unchecked, testosterone levels will continue to decline as you age, meaning that the average 50-year-old will have far less testosterone than the average 35-year-old, even though individuals are in a state of testosterone decline.

The effects of diminishing testosterone should be hardly noticeable for most men in their 30s. Once you hit 50, however, the effects may truly start to set in. Your sex drive may be reduced, you may have difficulty getting or maintaining an erection, your overall mood and energy may drop, and you may feel symptoms of irritability and even depression. Fortunately, the availability of testosterone replacement therapies for men over 50 means that you can break this cycle and regain at least some of the vitality you possessed as a young man.

VCLV Testosterone Replacement Therapy (TRT)offers physician prescribed and medically supervised Testosterone Therapy programs helping patients enter a cost effective and comprehensive Low Testosterone Treatment program designed to treat adult men over the age of 35 suffering from symptoms and problems associated with Low-T,hypogonadism and andropause also known as "male menopause".

Testosterone Replacement Therapy (TRT) with injectable testosterone, testosterone cream or gel can help men with low testosterone levels. Testosterone treatment is carefully formulated to help alleviate symptoms due to male menopause - Low T.

Treat low testosterone symptoms: loss of energy; low sex drive; erectile dysfunction; loss of muscle tone; irritability; depression; insomnia, feeling tired all the time bordering on fatigue; loss of focus and drive.

View post:
Testosterone Replacement Therapy Vivacity Clinic of Las ...

Trystan Reese, a transgender man, gave birth to a healthy boy on July 14 in Portland, Ore. (Amber Ferguson/The Washington Post)

Trystan Reese and his partner, Biff Chaplow, were already seasoned parents when they decided last year that they wanted another child.

Years earlier, they had adopted Chaplows niece and nephew after his sister was no longer able to take care of them. They raised the two children as their own, bringing them up in Los Angeles, where Reese and Chaplow worked in nonprofits, then moving the family to Portland, Ore., where they live now.

Adoption was a taxing process, Reese said, and learning how to care for two toddlers ushered ina suite of new challenges and lifestyle changes, as it does for any parent. Butit was also eye-opening.

After the dust settled, I just realized how much I loved our kids, Reese told The Washington Post, and how much room there was in our life for our family to grow.

After trying for several months, Reese, a transgender man,got pregnant. And just weeks ago, he gave birth to a healthy baby boy.

Reeseand Chaplow documented the pregnancy in blog posts and on social media, hoping to demystify what it means for atransgender man to give birth and to create a new sense of normalcy for people in similar situations.

Their familys story and their willingness to go public with itreflects a shift in public attitudes about pregnancy and parenting in transgender men as social stigmas have started to chipaway and advocacy groupshavecampaigned for greater acceptance.

Reese and Chaplow, perhaps more than anything else, want to make one thing clear: They are not the first. Far from it.

People get the idea that this was some experiment that we embarked on, Reese said, adding that he watched friends go through the same process after transitioning. This is tested ground. This is something that has been done in a very safe and healthy way. Were loath to be put in that pioneer category.

A number of transgender men havegone through successful pregnancies in recent years and throughout history, for that matter some of them long afterbeginninghormone replacement therapy. In one well-known example, the Village Voice published a narrative about Matt Rice, a transgender manwho conceived in 1999 through artificial insemination and gave birth to a baby boy. Other more recent pregnancies among transgender men have been well documented in media reports.

Reese, 34, was assigned female sex at birth and lived as a woman untilhis late teens.After counseling, he began taking hormones around age 20and started identifying as a man.He met Chaplow nearly eight years ago and said it was love at first sight. They took custody of Chaplows sisters children in 2011.

When they decided tohave a biological child, they sought out medical advice. Doctors told them that because Reese had only undergone hormone therapyin his transition, preparingto conceivewouldnt be very different than fora woman who had been on hormonal birth control.

Reese said he became pregnant about five months after he stopped taking testosterone.

When I found out, it was equal parts elation and fear, he said. I was soexcited to be on this journey with the person that I love, and then also really scared.Could I do this? Pregnancy is hard, labor is hard, and I hoped that Id be able to handle it all.

When Reese was six months along, he addressed peoples curiosities and misconceptions about his pregnancy in a videohe shared on social media. Sitting on his couch with a melon-sized bump under his shirt, he explained how the testosterone he took caused him to grow facial hair and made his voice drop but left him with a functioninguterus and ovaries.

Ive never wished or wanted to be assigned male at birth or to have my body match up exactly with that of my partner, who was assigned male at birth, Reese said. Im okay being trans. I think its kind of awesome, actually, and Ive never wanted my body to be different.

If you can understand that then it starts to make more sense that it would not seem totally bizarre for me to want to create and carry a baby, because I dont wish that my body was not a trans body, he said. Im okay being a man who has a uterus and who has the capacity and capability of carrying a baby.

Reeses pregnancy had all the ups and downs of any pregnancy, complete with swollen feet, fatigue, mood swings and all the anticipation and excitement that comes with bringing a child into the world, he said.

On July 14, after 30 hours of labor, Reese gave birth to Leo, a 9.5-pound baby who he says is in great health.

Reese told The Post henever imagined his life would take such a turn whenhe began his gender transition some 14 years ago.

I didnt think I would ever find someone I would fall in love with and would be with me. Being able to adopt two brilliant, funny, sweet kids was something that I never dreamed of. The fact that any of this happened has been a total surprise to me, because thats not the trans story were told, that love is possible, that being a loving family is possible.

More from Morning Mix:

After months of bullying, a 12-year-old New Jersey girl killed herself. Her parents blame the school.

Ohio man stored exs body in freezer, while living in her house with new girlfriend, prosecutors say

Why a TV station flew a drone over Kentucky governors home

See original here:
Transgender man gives birth to baby boy. 'Love is possible,' he says. So is 'being a loving family.' - Washington Post

Global Testosterone Replacement Therapy Market Research Report 2017 to 2022presents an in-depth assessment of the Testosterone Replacement Therapy including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for Testosterone Replacement Therapy investments from 2017 till 2022.

This study answers several questions for stakeholders, primarily which market segments they should focus upon during the next five years to prioritize their efforts and investments. The Testosterone Replacement Therapy markets are highly fragmented due to the presence of numerous small and large vendors. Most of the international pharmaceutical companies are facing challenges such as price pressure, regulatory constraints, and competition from local and other international pharmaceutical companies in the Testosterone Replacement Therapy markets. The competitive environment in the market is expected to intensify with an increase in product extensions, technological innovations, and increase in mergers and acquisitions.

These stakeholders include Testosterone Replacement Therapy manufacturers such as : AbbVie, Pfizer, Eli Lilly, Teva Pharmaceuticals, Mylan, Bayer HealthCare Pharmaceuticals, Antares Pharma, Ferring Pharmaceuticals, Allergan, Antares Pharma, Sandoz, Clarus Therapeutics, Juniper Pharmaceuticals, Endo International, Acerus Pharmaceuticals, Forendo Pharma, MetP Pharma, Repros Therapeutics.

Inquire for sample of report @:

https://www.marketinsightsreports.com/reports/07317183/global-testosterone-replacement-therapy-market-research-report-2017/inquiry

Primary sources are mainly industry experts from core and related industries, and suppliers, manufacturers, distributors, service providers, and organizations related to all segments of the industrys supply chain. The bottom-up approach was used to estimate the global market size of Testosterone Replacement Therapy based on end-use industry and region, in terms of value. With the data triangulation procedure and validation of data through primary interviews, the exact values of the overall parent market, and individual market sizes were determined and confirmed in this study.

Secondly the study, besides estimating the Testosterone Replacement Therapy market potential till 2022, analyzes on who can be the market leaders and what partnerships would help them to capture the market share. The report gives an overview about the dynamics of the market, by discussing various aspects such as drivers, restraints, Porters 5 forces, value chain, customer acceptance and investment scenario.

TheGlobal Testosterone Replacement Therapy marketconsists of different international, regional, and local vendors. The market competition is foreseen to grow higher with the rise in technological innovation and M&A activities in the future. Moreover, many local and regional vendors are offering specific application products for varied end-users. The new vendor entrants in the market are finding it hard to compete with the international vendors based on quality, reliability, and innovations in technology.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Global Testosterone Replacement Therapy Sales (K Units) and Revenue (Million USD) Market Split by Product Type:

Global Testosterone Replacement Therapy Sales (K Units) by Application (2016-2022)

by Application

(2016-2022)

The research provides answers to the following key questions:

This independent 112 page report guarantees you will remain better informed than your competition. With over 150 tables and figures examining the Testosterone Replacement Therapy market, the report gives you a visual, one-stop breakdown of the leading products, submarkets and market leaders market revenue forecasts as well as analysis to 2022.

Browse Full Report @:

https://www.marketinsightsreports.com/reports/07317183/global-testosterone-replacement-therapy-market-research-report-2017

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), and market share and growth rate of Storage Area Network Switch in these regions, from 2012 to 2022 (forecast), covering

by Regions

The report provides a basic overview of the Testosterone Replacement Therapy industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures.

Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share and contact information. Whats more, the Testosterone Replacement Therapy industry development trends and marketing channels are analyzed.

The report segments this market based on products, portability, methods, applications, and end users. Among various end users, the hospitals segment is expected to account for the largest share of the market and is expected to grow at the highest CAGR from 2014 to 2019. The high growth in this segment can be attributed to the rising rate of maternal mortality and fetal birth defects, and increasing number of initiatives taken by government organizations for improving prenatal care.

The research includes historic data from 2012 to 2016 and forecasts until 2022 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs. The report will make detailed analysis mainly on above questions and in-depth research on the development environment, market size, development trend, operation situation and future development trend of Testosterone Replacement Therapy on the basis of stating current situation of the industry in 2017 so as to make comprehensive organization and judgment on the competition situation and development trend of Testosterone Replacement Therapy Market and assist manufacturers and investment organization to better grasp the development course of Testosterone Replacement Therapy Market.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

There are 15 Chapters to deeply display the global Testosterone Replacement Therapy market.

Chapter 1, to describe Testosterone Replacement Therapy Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Grain and Seed Cleaning Equipment, with sales, revenue, and price of Grain and Seed Cleaning Equipment, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Grain and Seed Cleaning Equipment, for each region, from 2012 to 2017;

Chapter 5, 6, 7,8and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Testosterone Replacement Therapy market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Testosterone Replacement Therapy sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

The rest is here:
Testosterone Replacement Therapy Market Research Strategy 2017 - Equity Insider (press release)

Testosterone Replacement Therapy Market analysis report contains all study material about Market Overview, Growth, Demand and Forecast Research in all over the world. This report offers some penetrating overview and solution in the complex world of Testosterone Replacement Therapy Market.

In this report, the Testosterone Replacement Therapy Market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Detailed TOC and Charts & Tables of Testosterone Replacement Therapy Market Research Report available at- https://www.absolutereports.com/11137583

The report then analyses company profiles and the growth strategies of the major Testosterone Replacement Therapy Market leaders. A detailed study of product picture and specifications, revenue, cost, price, gross, capacity and production, company profiles, and contact information is carried out in the analysis of Testosterone Replacement Therapy industry key manufacturers section.

The following firms are included in the Testosterone Replacement Therapy Market report:

Get a Sample of Testosterone Replacement Therapy Market research report from https://www.absolutereports.com/enquiry/request-sample/11137583

Various stakeholders like investors, CEOs, traders, suppliers and others can use this report for complete understanding of the market.

A thorough analysis of price, market share, and gross margin on the basis of product type, price levels, and applications is done in the price and gross margin analysis section of the Testosterone Replacement Therapy Market research report.

Several important topics included in the Testosterone Replacement Therapy Market research report are as follows:

Further in the Testosterone Replacement Therapy Market analysis report, the Testosterone Replacement Therapy Market is examined for price, cost and gross. These three points are analysed for types, companies and regions. In continuation with this data sale price is for various types, applications and region is also included. The Testosterone Replacement Therapy Market for major regions is given. Additionally, type wise and application wise consumption figures are also given. New investment feasibility analysis and Testosterone Replacement Therapy Market growth is also included in the report.

By Product Analysis:

Regions covered in the Testosterone Replacement Therapy Market report:

By End Users/Applications Analysis:

Report includes chapters which deeply display the following deliverable about industry

Excerpt from:
Testosterone Replacement Therapy Market: By Key Players, Market Competitive Situation, Trends and Forecasts to 2022 - Green Mountain Outlook

Testosterone:is used to increase and optimize hormone levels.

HCG is used to prevent testicular shrinkage and maintain natural production of male hormone within the testes.

Estrogen Blockeris used to control the levels ofestrogen within a mans body.

Our doctors have designed a safe and proven program for our patients to maximize many benefits which include but are not limited to:

Increased muscle mass

Increased libido

Reduced fat

Improved sexual performance

Helps with cholesterol

Strengthens bones

Helps with diabetes

Sharpens mind

Improves mood

Improves skin tone and elasticity

increases energy and stamina

These benefits are seen when low hormone levels are treated in hypogonadal and andropausal men.

Following the Dr.s protocol is critical in achieving maximum results.

*Patients using Testosterone should seek medical attention immediately if symptoms of a heart attack or stroke are present, such as:

Read more:
Testosterone Replacement Therapy - Hormone Therapy